Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ORION-OYJ-1412508/news/ARASENS-trial-with-darolutamide-in-combination-with-docetaxel-and-androgen-deprivation-therapy-meets-37200180/?utm_source=whatsapp&utm_medium=social&utm_campaign=share